2000 Liz Tilberis Grant Recipient – Karen H. Lu
Karen H. Lu, M.D.
MD Anderson Cancer Center
Understanding the molecular differences in histologic grades of ovarian cancer: Implications for discovering new prognostic markers
Dr. Lu’s main clinical interests include the surgical and medical treatment of women with ovarian and endometrial cancers, as well as the management of women at genetically high risk for these cancers. She is Co-Director for Clinical Cancer Genetics and Director of the High Risk Ovarian Cancer Screening Clinic.
Dr. Lu is Co-Director of the Endometrial Cancer Research Program and Co-Principal Investigator of the Uterine Cancer Specialized Program of Research Excellence. She is the Principal Investigator for an NIH-sponsored chemoprevention study of women at high risk for developing endometrial cancer as well as for several nation-wide studies to develop and test novel markers and screening strategies for the early detection of ovarian cancer. In addition, she participates in research to apply laboratory-based findings to improving the care of gynecologic cancer patients. She receives support for her research from the National Cancer Institute, the Lynne Cohen Foundation, the American Gynecologic and Obstetric Society, and the Ovarian Cancer Research Fund. She has published numerous articles and book chapters and lectures extensively.
Dr. Lu is a Fellow of the American College of Obstetricians and Gynecologists, and a member of the Society of Gynecological Oncologists, the American Society of Clinical Oncologists and the American Association for Cancer Research.
The five-year survival rate for ovarian cancer has increased by only 8% in the last 30 years.
We are at a critical crossroads for supporting research into unlocking the mysteries of ovarian cancer. You can make a difference by supporting the research of the Ovarian Cancer Research Fund.
Help us find a cure for ovarian cancer. Donate online and make a difference.